Paracetamol treatment for patent ductus arteriosus: practice and attitudes in Australia and New Zealand

References

• Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900.
   PubMed Web of Science ®Google Scholar
• Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020–1030.
   PubMed Web of Science ®Google Scholar
• Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med. 2000;343:728–730.
   PubMed Web of Science ®Google Scholar
• Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995;126:605–610.
   PubMed Web of Science ®Google Scholar
• Mitra S, Florez ID, Tamayo ME, et al. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis. BMJ Open. 2016;6:e011271.
   PubMed Web of Science ®Google Scholar
• Hammerman C, Bin-Nun A, Kaplan M. Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol. 2012;36:130–138.
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 2000;343:674–681.
   PubMed Web of Science ®Google Scholar
• Fujii AM, Brown E, Mirochnick M, et al. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol. 2002;22:535–540.
   PubMedGoogle Scholar
• Nagaraj HS, Sandhu AS, Cook LN, et al. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg. 1981;16:1003–1007.
   PubMed Web of Science ®Google Scholar
• Shorter NA, Liu JY, Mooney DP, et al. Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg. 1999;34:442–444.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Rossetti A, Messina G, et al. Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. J Matern Fetal Neonatal Med. 2013;26:423–429.
   PubMed Web of Science ®Google Scholar
• Patel J, Roberts I, Azzopardi D, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res. 2000;47:36–42.
   PubMed Web of Science ®Google Scholar
• Coceani F, White E, Bodach E, et al. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol. 1979;57:825–831.
   PubMed Web of Science ®Google Scholar
• Rao R, Bryowsky K, Mao J, et al. Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus. J Perinatol. 2011;31:465–470.
   PubMed Web of Science ®Google Scholar
• Dang D, Wang D, Zhang C, et al. Comparison of Oral paracetamol versus ibuprofen in Premature Infants with patent ductus arteriosus: a randomized controlled trial. PLoS One. 2013;8:e77888.
   PubMed Web of Science ®Google Scholar
• Hammerman C, Bin-Nun A, Markovitch E, et al. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128:e1618–e1621.
   PubMed Web of Science ®Google Scholar
• Ho CH, Galiza G, Ebrahimi M, et al. Paracetamol-induced ductal closure in a 5-month-old infant. Cardiol Young. 2015;25:400–401.
   PubMed Web of Science ®Google Scholar
• Nadir E, Kassem E, Foldi S, et al. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol. 2014;34:748–749.
   PubMed Web of Science ®Google Scholar
• Özdemir OM, Doğan M, Küçüktaşçı K, et al. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol. 2014;35:276–279.
   PubMed Web of Science ®Google Scholar
• Kessel I, Waisman D, Lavie-Nevo K, et al. Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series. J Matern Fetal Neonatal Med. 2014;27:1719–1721.
   PubMed Web of Science ®Google Scholar
• Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology. 2013;103:166–169.
   PubMed Web of Science ®Google Scholar
• Valerio E, Valente MR, Salvadori S, et al. Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr. 2016;175:953–966.
   PubMed Web of Science ®Google Scholar
• Tekgunduz KS, Ceviz N, Demirelli Y, et al. Intravenous paracetamol for patent ductus arteriosus in premature infants – a lower dose is also effective. Neonatology. 2013;104:6–7.
   PubMed Web of Science ®Google Scholar
• Sinha R, Negi V, Dalal SS. An interesting observation of PDA closure with oral paracetamol in preterm neonates. J Clin Neonatol. 2013;2:30–32.
   PubMedGoogle Scholar
• Terrin G, Conte F, Scipione A, et al. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr. 2014;40:21.
   PubMed Web of Science ®Google Scholar
• Memisoglu A, Alp Ünkar Z, Cetiner N, et al. Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment. J Matern Fetal Neonatal Med. 2016;29:987–990.
   PubMed Web of Science ®Google Scholar
• Oncel MY, Yurttutan S, Uras N, et al. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98:F94.
   PubMed Web of Science ®Google Scholar
• Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013;(3):CD003951.
   Google Scholar
• El-Khuffash A, James AT, Cleary A, et al. Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed. 2015;100:F253–F256.
   PubMed Web of Science ®Google Scholar
• Tan ZH, Baral VR. Principles of clinical management of patent ductus arteriosus in extremely preterm neonates. Curr Pediatr Rev. 2016;12:83–97.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev. 2015;(3):CD010061.
   Google Scholar
• van den Anker JN, Allegaert K. Acetaminophen to prevent symptomatic patent ductus arteriosus: another drug bites the dust? J Pediatr. 2016;177:7–9.
   PubMed Web of Science ®Google Scholar
• Terrin G, Conte F, Oncel MY, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2016;101:F127–FF136.
   PubMed Web of Science ®Google Scholar
• Sivanandan S, Agarwal R. Pharmacological closure of patent ductus arteriosus: selecting the agent and route of administration. Pediatr Drugs. 2016;18:123–138.
   PubMed Web of Science ®Google Scholar
• El-Mashad AE, El-Mahdy H, El Amrousy D, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176:233–240.
   PubMed Web of Science ®Google Scholar
• Bagheri MM, Niknafs P, Sabsevari F, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr. 2016;26:e3975.
   PubMed Web of Science ®Google Scholar
• Dash SK, Kabra NS, Avasthi BS, et al. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatr. 2015;52:573–578.
   PubMed Web of Science ®Google Scholar
• Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus Oral ibuprofen in the Management of patent ductus arteriosus in preterm Infants: a randomized controlled trial. J Pediatr. 2014;164:510–514.e1.
   PubMed Web of Science ®Google Scholar
• Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Exp Ther Med. 2016;12:2531–2536.
   PubMed Web of Science ®Google Scholar
• Härkin P, Härmä A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr. 2016;177:72–77.e2.
   PubMed Web of Science ®Google Scholar